COMPANY PROFILE

GeneCker

Explore full profile

Through precise genetic analysis solutions, they lead the gene-diagnosis industry

Seoul, South KoreaFounded 2017Biotech & Life Sciences

Valuation $50–100M Last recorded · 2025

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About GeneCker

Genecker is a pioneering company in the genetic diagnosis industry, specializing in precise genetic analysis solutions. The company operates in the field of clinical diagnosis and personal genomes, focusing on achieving precision medicine. Genecker serves a diverse range of clients, including healthcare providers, research institutions, and individual consumers seeking personalized genetic information. The company is based in Seoul, South Korea, and has a dedicated GMP (Good Manufacturing Practice) production and product development team. Genecker's business model revolves around providing cutting-edge genetic analysis services and products, generating revenue through service fees and product sales. The company is actively investing in research and development to stay at the forefront of genetic diagnostics and precision medicine.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2017
Headquarters: Seoul, South Korea
Employees: 12
Open positions: None listed
Dealroom signal: 87.2/100
Industry: Health
Sub-industry: Pharmaceutical, BioTechnology
Sector: Biotech & Life Sciences, Genetics and genomics, Precision Medicine, Health Diagnostics, Spinout, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

6 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES C✓Equity / VC	Dec 2025	$13M	$50M	A-Ventures · Aju Pharma	↗
SERIES B✓Equity / VC	May 2022	$6.7M	$27M	Magna Investment · COVENT CAPITAL PARTNERS · UTC Investment · Premier Partners	↗

Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

GeneCker website traffic

Latest recorded traffic for GeneCker is 860 monthly website visits, down 59% over the last three months. GeneCker's team grew 200% over the past year.

Latest monthly visits860 3-month web change-59% 1-year team growth+200%

Monthly website visitsMay 2024–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
GEGENECASTUltra-sensitive liquid biopsy technology for early cancer detection and monitoring, enhancing diagnosis and treatment outcomes	Seoul, South Korea	Operational	16	$40M	$108M
MIMicrobaMicrobial genomics company	Brisbane, Australia	Operational
INInflammatixDeveloping novel molecular diagnostics for acute infections and sepsis that work by 'reading' the immune system	Sunnyvale, United States	Operational
TATagomicsMultiomic platform for disease biomarker discovery and diagnostics	Cambridge, United Kingdom	Operational
MAMoonlight AIThe company uses AI and machine learning to analyze genomic data	Courroux, Switzerland	Operational
BIBiofidelityRapid genomic biomarker detection for precision oncology	Cambridge, United Kingdom	Operational
SESema4Health intelligence company and a leader in diagnostic testing	Stamford, United States	Operational
SESeqOneImproving patient outcome by making improved genomic analysis accessible to all	Montpellier, France	Operational